ESR1 and breast carcinoma: The main types of therapies used for ER+ breast cancer include selective estrogen receptor modulators (SERMs), such as tamoxifen (TAM), selective estrogen receptor degraders (SERDs), such as fulvestrant, or AIs, such as letrozole, anastrozole, and exemestane.